Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Daewoong Pharmaceutical says anti-parasitic drug effective against coronavirus in animal tests
Daewoong Pharmaceutical says anti-parasitic drug effective against coronavirus in animal tests
South Korea's Daewoong Pharmaceutical said its anti-parasitic drug niclosamide had eliminated the novel coronavirus from animals' lungs during testing.
FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Today, the U.
AstraZeneca, Gilead merger doubted by Wall Street analysts
AstraZeneca, Gilead merger doubted by Wall Street analysts
(Reuters) - A merger between AstraZeneca (AZN.
Avigan trial to stretch beyond June as Japan's coronavirus cases plunge
Avigan trial to stretch beyond June as Japan's coronavirus cases plunge
TOKYO -- Potential coronavirus treatment Avigan is now expected to take until July at the earliest to complete a clinical trial, further delaying government approval in Japan, Nikkei has learned.
AZ' Calquence shows promise for COVID-19
AZ' Calquence shows promise for COVID-19
AstraZeneca says new analysis shows that its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) cut markers of inflammation and improved clinical outcomes of patients...
Imperial College London forms new social enterprise
Imperial College London forms new social enterprise
Imperial College London has established a new social enterprise VacEquity Global Health (VGH) to ensure that its COVID-19 vaccine has global reach.
Lilly bags expanded EU approval for Taltz
Lilly bags expanded EU approval for Taltz
The European Medicines Agency has expanded the reach of Lilly's Taltz (ixekizumab) to include the treatment of adults with active ankylosing spondylitis and active non-radiographic axial s...
AstraZeneca Forges RNA-Modifying Protein Oncology Deal with Accent Therapeutics
AstraZeneca Forges RNA-Modifying Protein Oncology Deal with Accent Therapeutics
Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.
Department of Defense Awards Novavax $60 Million COVID-19 Vaccine Contract
Department of Defense Awards Novavax $60 Million COVID-19 Vaccine Contract
Novavax is one of the U.
Abbvie strikes partnership to develop COVID-19 antibody therapy
Abbvie strikes partnership to develop COVID-19 antibody therapy
(Reuters) - U.
Pharma sees more post-M&A rebrands than other industries—and it does them better, too
Pharma sees more post-M&A rebrands than other industries—and it does them better, too
To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries.
NICE publishes final guidance backing Teva's Ajovy for migraine
NICE publishes final guidance backing Teva's Ajovy for migraine
The National Institute for Health and Care Excellence (NICE) has now published final guidelines endorsing the NHS use of Teva’s Ajovy (fremanezumab) to prevent migraine.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand